Evaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform

[ad_1] COPENHAGEN, Denmark, April 13, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in AI-powered immunotherapies, announces the successful publication in Frontiers of Immunology…

Global Pharma and Biotech Discovery Stage Partnering Analysis and Trends Report 2023: What do Companies Spend on Discovery, Preclinical and Clinical Stage Partnering

[ad_1] DUBLIN, March 21, 2023 /PRNewswire/ — The “Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2016 – 2023” report has been added to ResearchAndMarkets.com’s offering. Research and…